Vigabatrin, identified by CAS 60643-86-9, is a significant pharmaceutical intermediate renowned for its potent anticonvulsant properties. Its therapeutic efficacy stems from its role as a selective, irreversible inhibitor of gamma-aminobutyric acid transaminase (GABA-T). By blocking this enzyme, Vigabatrin enhances the availability of GABA, the brain's primary inhibitory neurotransmitter, thereby reducing neuronal excitability and mitigating seizure activity. This mechanism makes it a vital compound for research and clinical applications targeting epilepsy.

For professionals in the pharmaceutical industry and research laboratories, obtaining high-quality Vigabatrin is essential for accurate and reproducible results. As a leading Vigabatrin manufacturer and supplier, we are committed to providing a product that meets rigorous purity standards. Our operations in China ensure a stable and cost-effective supply chain, enabling researchers to buy Vigabatrin without compromising on quality. Whether you are involved in preclinical studies, drug formulation, or large-scale synthesis, understanding the implications of sourcing from a trusted Vigabatrin supplier is key to success.

The applications of Vigabatrin are primarily focused on treating specific forms of epilepsy, such as refractory complex partial seizures and infantile spasms, where other treatments have proven insufficient. Its ability to modulate GABAergic neurotransmission makes it a cornerstone in epilepsy research and treatment development. We encourage you to explore our offerings and to inquire about our Vigabatrin price for bulk purchases. Partnering with a knowledgeable GABA-T inhibitor supplier like us can significantly streamline your procurement process and support your critical research objectives.